AGO2 and cancer: Blocking Ago2/CAV1 interaction in cancer cells with P2 peptides decreased the migration and invasion of A549 cancer cells (Fig. 4Ei) and HCC1806 cancer cells (Fig. 4Eii) in Boyden chambers.